88 related articles for article (PubMed ID: 18793962)
21. Intensity Modulated Proton Beam Therapy versus Volumetric Modulated Arc Therapy for Patients with Nasopharyngeal Cancer: A Propensity Score-Matched Study.
Chou YC; Fan KH; Lin CY; Hung TM; Huang BS; Chang KP; Kang CJ; Huang SF; Chang PH; Hsu CL; Wang HM; Hsieh JC; Cheng AJ; Chang JT
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298769
[TBL] [Abstract][Full Text] [Related]
22. A Systematic Review of Proton Therapy for the Management of Nasopharyngeal Cancer.
Lee A; Kitpanit S; Chilov M; Langendijk JA; Lu J; Lee NY
Int J Part Ther; 2021; 8(1):119-130. PubMed ID: 34285941
[TBL] [Abstract][Full Text] [Related]
23. PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors.
Lin A; Chang JHC; Grover RS; Hoebers FJP; Parvathaneni U; Patel SH; Thariat J; Thomson DJ; Langendijk JA; Frank SJ
Int J Part Ther; 2021; 8(1):84-94. PubMed ID: 34285938
[TBL] [Abstract][Full Text] [Related]
24. Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.
Cao J; Zhang X; Jiang B; Chen J; Wang X; Wang L; Sahoo N; Zhu XR; Ye R; Blanchard P; Garden AS; Fuller CD; Gunn GB; Frank SJ
Radiother Oncol; 2021 Jul; 160():32-39. PubMed ID: 33839202
[TBL] [Abstract][Full Text] [Related]
25. Patient-Derived Nasopharyngeal Cancer Organoids for Disease Modeling and Radiation Dose Optimization.
Lucky SS; Law M; Lui MH; Mong J; Shi J; Yu S; Yoon DK; Djeng SK; Wang J; Lim CM; Tan MH
Front Oncol; 2021; 11():622244. PubMed ID: 33732646
[TBL] [Abstract][Full Text] [Related]
26. Potential benefits of adaptive intensity-modulated proton therapy in nasopharyngeal carcinomas.
Minatogawa H; Yasuda K; Dekura Y; Takao S; Matsuura T; Yoshimura T; Suzuki R; Yokota I; Fujima N; Onimaru R; Shimizu S; Aoyama H; Shirato H
J Appl Clin Med Phys; 2021 Jan; 22(1):174-183. PubMed ID: 33338323
[TBL] [Abstract][Full Text] [Related]
27. Proton pencil-beam scanning radiotherapy in the treatment of nasopharyngeal cancer: dosimetric parameters and 2-year results.
Jiří K; Vladimír V; Michal A; Matěj N; Silvia S; Pavel V; Kateřina D; Jana P; Barbora O; Eliška R; Petr L; Matěj P; Alexander G; Jozef R
Eur Arch Otorhinolaryngol; 2021 Mar; 278(3):763-769. PubMed ID: 32623508
[TBL] [Abstract][Full Text] [Related]
28. Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors.
McDowell L; Corry J; Ringash J; Rischin D
Front Oncol; 2020; 10():930. PubMed ID: 32596155
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Pencil Beam Scanning Proton- and Photon-Based Techniques for Carcinoma of the Parotid.
Swisher-McClure S; Teo BK; Kirk M; Chang C; Lin A
Int J Part Ther; 2016 Mar; 2(4):525-532. PubMed ID: 31772964
[TBL] [Abstract][Full Text] [Related]
30. New frontiers in proton therapy: applications in cancers.
Yuan TZ; Zhan ZJ; Qian CN
Cancer Commun (Lond); 2019 Oct; 39(1):61. PubMed ID: 31640788
[TBL] [Abstract][Full Text] [Related]
31. Update in pediatric nasopharyngeal undifferentiated carcinoma.
Claude L; Jouglar E; Duverge L; Orbach D
Br J Radiol; 2019 Oct; 92(1102):20190107. PubMed ID: 31322911
[TBL] [Abstract][Full Text] [Related]
32. Future of Radiotherapy in Nasopharyngeal Carcinoma.
Sun XS; Li XY; Chen QY; Tang LQ; Mai HQ
Br J Radiol; 2019 Oct; 92(1102):20190209. PubMed ID: 31265322
[TBL] [Abstract][Full Text] [Related]
33. Early clinical outcomes of helical tomotherapy/intensity-modulated proton therapy combination in nasopharynx cancer.
Park SG; Ahn YC; Oh D; Noh JM; Ju SG; Kwon D; Jo K; Chung K; Chung E; Lee W; Park S
Cancer Sci; 2019 Sep; 110(9):2867-2874. PubMed ID: 31237050
[TBL] [Abstract][Full Text] [Related]
34. Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience.
Jouin A; Helfre S; Bolle S; Claude L; Laprie A; Bogart E; Vigneron C; Potet H; Ducassou A; Claren A; Riet FG; Castex MP; Faure-Conter C; Fresneau B; Defachelles AS; Orbach D
Strahlenther Onkol; 2019 Jun; 195(6):504-516. PubMed ID: 30963203
[TBL] [Abstract][Full Text] [Related]
35. Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control.
Akbaba S; Held T; Lang K; Forster T; Federspil P; Herfarth K; Häfner M; Plinkert P; Rieken S; Debus J; Adeberg S
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30884910
[No Abstract] [Full Text] [Related]
36. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.
Finazzi T; Rordorf T; Ikenberg K; Huber GF; Guckenberger M; Garcia Schueler HI
BMC Cancer; 2018 Apr; 18(1):395. PubMed ID: 29625593
[TBL] [Abstract][Full Text] [Related]
38. Technical Note: A treatment plan comparison between dynamic collimation and a fixed aperture during spot scanning proton therapy for brain treatment.
Smith B; Gelover E; Moignier A; Wang D; Flynn RT; Lin L; Kirk M; Solberg T; Hyer DE
Med Phys; 2016 Aug; 43(8):4693. PubMed ID: 27487886
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.
Kurz C; Nijhuis R; Reiner M; Ganswindt U; Thieke C; Belka C; Parodi K; Landry G
Radiat Oncol; 2016 Apr; 11():64. PubMed ID: 27129305
[TBL] [Abstract][Full Text] [Related]
40. Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients.
van Dijk LV; Steenbakkers RJ; ten Haken B; van der Laan HP; van 't Veld AA; Langendijk JA; Korevaar EW
PLoS One; 2016; 11(3):e0152477. PubMed ID: 27030987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
